Literature DB >> 8214864

Emergency department immunization of the elderly with pneumococcal and influenza vaccines.

R M Rodriguez1, L J Baraff.   

Abstract

STUDY
OBJECTIVE: To determine the feasibility of immunizing unvaccinated elderly patients with influenza and pneumococcal vaccines in the emergency department. PARTICIPANTS AND
SETTING: A convenience sample of elderly patients presenting to an urban university-affiliated ED. DESIGN AND
INTERVENTIONS: Elderly ED patients were asked about prior influenza and pneumococcal immunization. Nonimmunized patients were given information sheets, were informed of the changes for vaccination, and were asked if they desired immunization as part of their ED care. Those desiring immunization who lacked contraindications were immunized.
RESULTS: One hundred thirty-three patients were enrolled. Eighty-two percent had not been immunized with pneumococcal vaccine; 62% of these nonimmunized patients stated they desired pneumococcal vaccination, and 58% were immunized. Sixty-three percent of the 133 patients had not received current influenza vaccine; 54% of these nonimmunized patients stated they desired influenza vaccine, and 50% were immunized.
CONCLUSION: The majority of elderly ED patients are not immunized adequately with influenza and pneumococcal vaccines as recommended by the Centers for Disease Control and Prevention. Most elderly patients will accept immunization with these vaccines as part of their ED care. These vaccines can be delivered effectively to elderly patients in the ED.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214864     DOI: 10.1016/s0196-0644(05)81313-7

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  9 in total

1.  Emergency Department influenza vaccination campaign allows increasing influenza vaccination coverage without disrupting time interval quality indicators.

Authors:  Enrique Casalino; Aiham Ghazali; Donia Bouzid; Stephanie Antoniol; Philippe Kenway; Laurent Pereira; Christophe Choquet
Journal:  Intern Emerg Med       Date:  2018-05-25       Impact factor: 3.397

2.  Research priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment.

Authors:  Christopher R Carpenter; Kennon Heard; Scott Wilber; Adit A Ginde; Kirk Stiffler; Lowell W Gerson; Neal S Wenger; Douglas K Miller
Journal:  Acad Emerg Med       Date:  2011-06       Impact factor: 3.451

3.  A computerized pneumococcal vaccination reminder system in the adult emergency department.

Authors:  Judith W Dexheimer; Thomas R Talbot; Fei Ye; Yu Shyr; Ian Jones; William M Gregg; Dominik Aronsky
Journal:  Vaccine       Date:  2011-07-23       Impact factor: 3.641

4.  Influenza and pneumococcal vaccination in the emergency department: is it feasible?

Authors:  K Wrenn; M Zeldin; O Miller
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

5.  A Prospective, Randomized Trial in the Emergency Department of Suggestive Audio-Therapy under Deep Sedation for Smoking Cessation.

Authors:  Robert M Rodriguez; Opal Taylor; Sushma Shah; Susan Urstein
Journal:  West J Emerg Med       Date:  2007-08

Review 6.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

Review 7.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

Review 8.  The future of emergency medicine public health research.

Authors:  Karin V Rhodes; Daniel A Pollock
Journal:  Emerg Med Clin North Am       Date:  2006-11       Impact factor: 2.264

Review 9.  Communicable respiratory threats in the ED: tuberculosis, influenza, SARS, and other aerosolized infections.

Authors:  Richard E Rothman; Yu-Hsiang Hsieh; Samuel Yang
Journal:  Emerg Med Clin North Am       Date:  2006-11       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.